ExoAnalysis

Analytics Outputs

What's in the Report

What It Answers	What It Tells an Investor or Board
Where the Company Is Valued Today	A valuation assessment covering share price, analyst consensus rating, trailing and peer/industry P/E, PEG ratio and recent analyst targets — the baseline every horizon below is measured against. Where no traded multiple exists, that is stated rather than estimated.
What the Next Twelve Months Turn On	The one-year horizon: the specific catalysts and failure modes that would move the position within the year, each tied to an observable event rather than a sentiment.
Where the Medium-Term Risk Concentrates	The three-year horizon: the central case and the structural forces — adoption, funding, competitive substitution — most likely to compound in either direction over that span.
What the Long Horizon Depends On	The five-year horizon: the durable dependencies and regulatory shifts that decide whether today's position is defensible or eroded.
The Upside and Downside, Side by Side	A summary matrix pairing each upside catalyst against its corresponding downside risk, so the asymmetry of the position is legible at a glance rather than argued across pages.
What to Watch, Specifically	Named, checkable signals — a financing event, a named customer, an ownership or scale change — that would confirm or falsify the assessment, plus full sourcing and qualification of the evidence base.

Key Use Cases

Portfolio monitoring Investment committee Diligence supplement Risk horizon review

Report Pairing

Reads as a supplement to ExoAnalysis, which supplies the external diagnostic this risk horizon is built on. It is a standalone deliverable and does not require a survey.